Evogene Ltd. - Capital/Financing Update 2023

Evogene Announces Pricing of US$8,500,000 Registered Direct Offering false


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	17/07/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-081252	Time of broadcast: 14:21 14:21

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onEvogene Announces Pricing of US$8,500,000 Registered Direct Offering

a2329982_accessible_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 20/06/2023
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected] Company site: www.evogene.com

Previous names of reporting entity:

Name of the Signatory: Kofman Guy Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company:
Address: Gad Feinstein St. 13 , Rehovot 7638517 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1

AI assistant